Key Highlights

  • agilon health shares are trading at $83.63 in Thursday's session, up 5.07%.
  • The Jackson Clinic is joining agilon's Senior Health Connect ACO, which is expected to reach about 9,000 more Traditional Medicare beneficiaries in Tennessee.
  • agilon's ACOs have generated more than $510 million in gross savings since 2021, including $125 million for the Medicare Trust Fund.
  • The stock is recovering after a drop of roughly 30% over the past 90 days.

ACO Expansions Fuel a Rebound

agilon health (NYSE:AGL) is rising in Thursday's session as investors digest a run of accountable care organization Partnership expansions, the latest announced on September 30. The Westerville, Ohio-based company partners with community-based primary care physician groups to deliver value-based care to senior patients.

Shares are up about 5% at $83.63 on Volume running below average, recovering part of a roughly 30% decline over 90 days.

Jackson Clinic Adds About 9,000 Traditional Medicare Beneficiaries

The Jackson Clinic, one of Tennessee's largest independent physician organizations with more than 130 providers, is joining Senior Health Connect ACO, which participates in the Medicare Shared Savings Program. The clinic has worked with agilon since 2022 on a full-risk model that supports about 8,000 Medicare Advantage patients.

The expansion follows similar recent deals with other physician groups.

A Savings and Quality Record Anchors the Pitch

agilon's ACOs have produced more than $510 million in gross savings since 2021, including $125 million in savings to the Medicare Trust Fund, and averaged a 96% quality score in 2024. CEO Tim O'Rourke said accountable care lets physicians look beyond a single visit and emphasize prevention, earlier intervention and chronic disease management.

Cash Cushion Helps, but Risk Adjustment and Payer Concentration Remain

Commentary on the stock is mixed. A research firm points to a net cash position of about $155 million and a fair-value estimate near $111, while risks include lagging risk-adjustment Revenue and payer concentration. Shares trade within a wide 52-week range of $7.48 to $133.04.